+1 to mike.trainer_LA. Especially the point about "NateNeph perspective but I think this ov..." — I have seen the same in my own experience with Canadian GLP-1 coverage .
Want to share my personal experience related to Canadian GLP-1 coverage since I think it might help others in a similar situation.
I started my GLP-1 journey in October 2024 at 255 lbs with prediabetes and hypertension. My endocrinologist prescribed semaglutide 0.25mg to start.
Now, 10 months later: I am down 45 lbs, my labs have normalized, and I am off 2 of my 3 medications. The Canadian GLP-1 aspect specifically was something that made a big difference in my journey.
This community helped me every step of the way.
carl_compliance — that is really helpful context on Canadian GLP-1 coverage . Follow-up question: did you experience any side effects during this phase?
I am in a similar situation (about to start) and trying to set realistic expectations.
Community-driven peptide testing and vendor rating platform. Transparent results. Unbiased analysis. Trusted by thousands.
View ResultsTo answer DanielChem_CHI's question specifically:
From a clinical standpoint, Canadian GLP-1 coverage is something I discuss with patients regularly.
The short answer: discuss this specific situation with your prescribing provider.
The longer answer involves weighing the risk-benefit ratio for your individual situation, which I am happy to elaborate on if helpful.
Saving this for reference. Quality thread.